Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elmar A Joura

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Cervical cancer and vaccination--an overviewElmar A Joura
Current Opinion in Obstetrics & Gynecology|January 22, 2002
Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasiaElmar A Joura
Gynakologisch-Geburtshilfliche Rundschau|June 24, 2004
[Human papillomavirus and cervical cancer: presence and future of vaccination]Elmar A Joura
Wiener Medizinische Wochenschrift (1946)|April 12, 2007
[Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination]Lucia Six, Elmar A Joura
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 28, 2011
Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in womenPaul L McCormack, Elmar A Joura
Drugs|December 15, 2010
Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in womenPaul L McCormack, Elmar A Joura
Obstetrics and Gynecology|June 24, 2009
Cervical cancers after human papillomavirus vaccinationElmar A Joura, Suzanne M Garland
Obstetrics and Gynecology|February 19, 2026
In ReplyElmar A Joura, Anna R Giuliano
American Journal of Obstetrics and Gynecology|October 17, 2003
The impact of a single- or double-layer closure on uterine ruptureElmar A Joura, Andreas Nather, Maria Hohlagschwandtner, et al.
The Journal of Reproductive Medicine|March 9, 2002
A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tabletMichaela Rabl, Elmar A Joura, Yüksel Yücel, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Cervical cancer and vaccination--an overviewElmar A Joura
Current Opinion in Obstetrics & Gynecology|January 22, 2002
Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasiaElmar A Joura
Gynakologisch-Geburtshilfliche Rundschau|June 24, 2004
[Human papillomavirus and cervical cancer: presence and future of vaccination]Elmar A Joura
Wiener Medizinische Wochenschrift (1946)|April 12, 2007
[Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination]Lucia Six, Elmar A Joura
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 28, 2011
Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in womenPaul L McCormack, Elmar A Joura
Drugs|December 15, 2010
Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in womenPaul L McCormack, Elmar A Joura
Obstetrics and Gynecology|June 24, 2009
Cervical cancers after human papillomavirus vaccinationElmar A Joura, Suzanne M Garland
Obstetrics and Gynecology|February 19, 2026
In ReplyElmar A Joura, Anna R Giuliano
American Journal of Obstetrics and Gynecology|October 17, 2003
The impact of a single- or double-layer closure on uterine ruptureElmar A Joura, Andreas Nather, Maria Hohlagschwandtner, et al.
The Journal of Reproductive Medicine|March 9, 2002
A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tabletMichaela Rabl, Elmar A Joura, Yüksel Yücel, et al.
Pageof 7